Schedule 13G ownership disclosure
Precision BioSciences, Inc.
Common stock, par value $0.000005 per share · CUSIP: 74019P207
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Novartis Pharma AG
Shares: 413,581.00 · Class: 3.7%
- Novartis AG
Shares: 413,581.00 · Class: 3.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-074695
- Form type
- SCHEDULE 13G/A
- Filer
- NOVARTIS PHARMA AG
- CIK
- CIK 1030617
- Filed
- Aug 06, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership